These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 26760772)
1. Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686. Wu BH; Chen H; Cai CM; Fang JZ; Wu CC; Huang LY; Wang L; Han ZG Oncotarget; 2016 Feb; 7(6):6847-63. PubMed ID: 26760772 [TBL] [Abstract][Full Text] [Related]
2. Jmjd5, an H3K36me2 histone demethylase, modulates embryonic cell proliferation through the regulation of Cdkn1a expression. Ishimura A; Minehata K; Terashima M; Kondoh G; Hara T; Suzuki T Development; 2012 Feb; 139(4):749-59. PubMed ID: 22241836 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression. Ye J; Yao Y; Song Q; Li S; Hu Z; Yu Y; Hu C; Da X; Li H; Chen Q; Wang QK Sci Rep; 2016 Oct; 6():34034. PubMed ID: 27698442 [TBL] [Abstract][Full Text] [Related]
4. Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27. Wang D; Han S; Peng R; Jiao C; Wang X; Yang X; Yang R; Li X J Exp Clin Cancer Res; 2016 Feb; 35():37. PubMed ID: 26911146 [TBL] [Abstract][Full Text] [Related]
5. LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression. Xu X; Gu J; Ding X; Ge G; Zang X; Ji R; Shao M; Mao Z; Zhang Y; Zhang J; Mao F; Qian H; Xu W; Cai H; Wang F; Zhang X Cell Death Dis; 2019 Oct; 10(10):752. PubMed ID: 31582742 [TBL] [Abstract][Full Text] [Related]
6. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240 [TBL] [Abstract][Full Text] [Related]
7. JMJD5 interacts with p53 and negatively regulates p53 function in control of cell cycle and proliferation. Huang X; Zhang S; Qi H; Wang Z; Chen HW; Shao J; Shen J Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2286-95. PubMed ID: 26025680 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
9. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186 [TBL] [Abstract][Full Text] [Related]
10. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. Fornari F; Milazzo M; Chieco P; Negrini M; Marasco E; Capranico G; Mantovani V; Marinello J; Sabbioni S; Callegari E; Cescon M; Ravaioli M; Croce CM; Bolondi L; Gramantieri L J Pathol; 2012 Jul; 227(3):275-85. PubMed ID: 22262409 [TBL] [Abstract][Full Text] [Related]
11. Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells. Dong YW; Wang R; Cai QQ; Qi B; Wu W; Zhang YH; Wu XZ J Hepatol; 2014 Apr; 60(4):792-801. PubMed ID: 24333181 [TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA GATA3-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Suppression of PTEN, CDKN1A, and TP53. Luo X; Zhou N; Wang L; Zeng Q; Tang H Can J Gastroenterol Hepatol; 2019; 2019():1389653. PubMed ID: 31871924 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes. Ma L; Liu J; Liu L; Duan G; Wang Q; Xu Y; Xia F; Shan J; Shen J; Yang Z; Bie P; Cui Y; Bian XW; Prieto J; Avila MA; Qian C Cancer Res; 2014 Mar; 74(5):1452-62. PubMed ID: 24390737 [TBL] [Abstract][Full Text] [Related]
14. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway. Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916 [TBL] [Abstract][Full Text] [Related]
15. Early growth response 3 inhibits growth of hepatocellular carcinoma cells via upregulation of Fas ligand. Zhang S; Xia C; Xu C; Liu J; Zhu H; Yang Y; Xu F; Zhao J; Chang Y; Zhao Q Int J Oncol; 2017 Mar; 50(3):805-814. PubMed ID: 28098878 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A. Ohta K; Hoshino H; Wang J; Ono S; Iida Y; Hata K; Huang SK; Colquhoun S; Hoon DS Oncotarget; 2015 Feb; 6(5):3211-24. PubMed ID: 25633810 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of JMJD5 suppresses metastasis and induces apoptosis in oral squamous cell carcinoma by regulating p53/NF-κB pathway. Yao Y; Zhou WY; He RX Biomed Pharmacother; 2019 Jan; 109():1994-2004. PubMed ID: 30551455 [TBL] [Abstract][Full Text] [Related]
18. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554 [TBL] [Abstract][Full Text] [Related]